Search research articles
Contact Us
Filters
Showing results (51-60 of 64) with videos related to
Page
of 7
Sort By:
Communicable Diseases Intelligence (2018)
|
June 25, 2023
Creutzfeldt-Jakob disease surveillance in Australia: update to 31 December 2022
Christiane Stehmann, Matteo Senesi, Shannon Sarros, et al.
Communicable Diseases Intelligence (2018)
|
March 24, 2025
Creutzfeldt-Jakob disease surveillance in Australia: update to 31 December 2023
Christiane Stehmann, Matteo Senesi, Shannon Sarros, et al.
Plos Pathogens
|
April 11, 2019
Early existence and biochemical evolution characterise acutely synaptotoxic PrPSc
Simote Totauhelotu Foliaki, Victoria Lewis, Abu Mohammed Taufiqual Islam, et al.
Neuroscience Letters
|
January 29, 2010
No evidence for prion protein gene locus multiplication in Creutzfeldt-Jakob disease
Steven J Collins, Maaike Schuur, Alison Boyd, et al.
Biophysical Journal
|
June 21, 2020
PrPSc Oligomerization Appears Dynamic, Quickly Engendering Inherent M1000 Acute Synaptotoxicity
Simote T Foliaki, Victoria Lewis, Abu M T Islam, et al.
Frontiers in Neurology
|
February 27, 2023
Diagnostic performance of CSF biomarkers in a well-characterized Australian cohort of sporadic Creutzfeldt-Jakob disease
Matteo Senesi, Victoria Lewis, Shiji Varghese, et al.
Ebiomedicine
|
May 10, 2026
Identification of the ACTB p.Ser348Leu de novo variant in individuals with syndromic neonatal diabetes
Suhel Ahmed, Victoria Lewis, James Russ-Silsby, et al.
Brain Research Bulletin
|
December 27, 2005
Correlative studies support lipid peroxidation is linked to PrP(res) propagation as an early primary pathogenic event in prion disease
Marcus W Brazier, Victoria Lewis, Giuseppe D Ciccotosto, et al.
Plos Pathogens
|
August 9, 2018
Prion acute synaptotoxicity is largely driven by protease-resistant PrPSc species
Simote Totauhelotu Foliaki, Victoria Lewis, David Isaac Finkelstein, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
February 14, 2024
Alzheimer's disease biomarker utilization at first referral enhances differential diagnostic precision with simultaneous exclusion of Creutzfeldt-Jakob disease
Zitianyu Wang, Victoria Lewis, Christiane Stehmann, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 64) with videos related to
Sort By:
Page
of 7
Communicable Diseases Intelligence (2018)
|
June 25, 2023
Creutzfeldt-Jakob disease surveillance in Australia: update to 31 December 2022
Christiane Stehmann, Matteo Senesi, Shannon Sarros, et al.
Communicable Diseases Intelligence (2018)
|
March 24, 2025
Creutzfeldt-Jakob disease surveillance in Australia: update to 31 December 2023
Christiane Stehmann, Matteo Senesi, Shannon Sarros, et al.
Plos Pathogens
|
April 11, 2019
Early existence and biochemical evolution characterise acutely synaptotoxic PrPSc
Simote Totauhelotu Foliaki, Victoria Lewis, Abu Mohammed Taufiqual Islam, et al.
Neuroscience Letters
|
January 29, 2010
No evidence for prion protein gene locus multiplication in Creutzfeldt-Jakob disease
Steven J Collins, Maaike Schuur, Alison Boyd, et al.
Biophysical Journal
|
June 21, 2020
PrPSc Oligomerization Appears Dynamic, Quickly Engendering Inherent M1000 Acute Synaptotoxicity
Simote T Foliaki, Victoria Lewis, Abu M T Islam, et al.
Frontiers in Neurology
|
February 27, 2023
Diagnostic performance of CSF biomarkers in a well-characterized Australian cohort of sporadic Creutzfeldt-Jakob disease
Matteo Senesi, Victoria Lewis, Shiji Varghese, et al.
Ebiomedicine
|
May 10, 2026
Identification of the ACTB p.Ser348Leu de novo variant in individuals with syndromic neonatal diabetes
Suhel Ahmed, Victoria Lewis, James Russ-Silsby, et al.
Brain Research Bulletin
|
December 27, 2005
Correlative studies support lipid peroxidation is linked to PrP(res) propagation as an early primary pathogenic event in prion disease
Marcus W Brazier, Victoria Lewis, Giuseppe D Ciccotosto, et al.
Plos Pathogens
|
August 9, 2018
Prion acute synaptotoxicity is largely driven by protease-resistant PrPSc species
Simote Totauhelotu Foliaki, Victoria Lewis, David Isaac Finkelstein, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
February 14, 2024
Alzheimer's disease biomarker utilization at first referral enhances differential diagnostic precision with simultaneous exclusion of Creutzfeldt-Jakob disease
Zitianyu Wang, Victoria Lewis, Christiane Stehmann, et al.
Page
of 7